SPORTIELLO, Liberata
 Distribuzione geografica
Continente #
EU - Europa 5.337
NA - Nord America 3.302
AS - Asia 2.313
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 39
OC - Oceania 3
AN - Antartide 1
Totale 11.529
Nazione #
RU - Federazione Russa 3.638
US - Stati Uniti d'America 3.226
SG - Singapore 761
CN - Cina 560
IE - Irlanda 468
IT - Italia 467
VN - Vietnam 347
BR - Brasile 306
HK - Hong Kong 245
GB - Regno Unito 194
DE - Germania 160
UA - Ucraina 131
KR - Corea 99
JP - Giappone 83
IN - India 81
GR - Grecia 47
FI - Finlandia 46
CA - Canada 40
TR - Turchia 38
AR - Argentina 35
FR - Francia 35
SE - Svezia 27
NL - Olanda 23
EC - Ecuador 19
BD - Bangladesh 18
ID - Indonesia 18
ZA - Sudafrica 18
AT - Austria 15
BE - Belgio 13
CZ - Repubblica Ceca 12
ES - Italia 12
IQ - Iraq 12
MX - Messico 12
PL - Polonia 10
IR - Iran 8
JM - Giamaica 8
PK - Pakistan 8
CH - Svizzera 7
MA - Marocco 7
CL - Cile 6
IL - Israele 6
DK - Danimarca 5
EE - Estonia 5
PY - Paraguay 5
EG - Egitto 4
HN - Honduras 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
HR - Croazia 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PH - Filippine 2
RO - Romania 2
TN - Tunisia 2
AQ - Antartide 1
AU - Australia 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 11.377
Città #
Moscow 1.326
San Jose 548
Dublin 463
Singapore 359
Santa Clara 305
Hong Kong 243
Jacksonville 208
Ashburn 196
Chandler 176
Council Bluffs 154
Beijing 100
Ho Chi Minh City 98
Seoul 96
Hefei 78
Ann Arbor 68
Dong Ket 66
Hanoi 63
Aversa 57
Princeton 54
Roxbury 48
Medford 46
Bremen 45
Dallas 41
Los Angeles 35
New York 35
Woodbridge 35
Bengaluru 34
Orem 34
Milan 33
The Dalles 32
Naples 31
Atlanta 30
Caserta 28
Wilmington 28
Rome 27
São Paulo 27
Düsseldorf 26
Memphis 22
Mountain View 21
Nanjing 21
Da Nang 19
Genoa 18
Des Moines 17
Munich 16
San Francisco 16
Boardman 15
Dearborn 15
Amsterdam 14
Brussels 13
Cambridge 13
Chennai 13
London 13
Nuremberg 13
Toronto 13
Kunming 12
Jinan 11
Johannesburg 11
Chicago 10
Falkenstein 10
Frankfurt am Main 10
Haiphong 10
Helsinki 10
Manchester 10
Napoli 10
Biên Hòa 9
Jakarta 9
Phủ Lý 9
Auburn Hills 8
Hanover 8
Messina 8
Mexico City 8
Pomigliano d'Arco 8
Salerno 8
Brasília 7
Brno 7
Brooklyn 7
Chengdu 7
Curitiba 7
Guangzhou 7
Kingston 7
Mumbai 7
Rio de Janeiro 7
San Mateo 7
Shenyang 7
Stockholm 7
Vienna 7
Warsaw 7
Boston 6
Cagliari 6
Changsha 6
Columbus 6
Denver 6
Guarulhos 6
Hillsboro 6
Houston 6
Hải Dương 6
Montreal 6
Norwalk 6
Quito 6
Asunción 5
Totale 5.899
Nome #
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 356
Neutral endopeptidase (neprilysin) 238
Adverse drug reactions and gender differences: What changes in drug safety? 235
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 204
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 200
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 195
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 189
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 188
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 184
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 177
Complete resistance after maximal dose of rocuronium 177
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 174
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 168
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 168
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 167
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 165
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 164
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 162
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 162
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 159
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 159
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 158
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 157
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 153
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 152
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 151
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 149
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 147
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 146
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 145
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 144
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 143
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 143
Current pharmacological treatments for COVID-19: What's next? 143
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 142
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 140
Disclosing negative trial results – procedure 139
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 138
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 137
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 136
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 135
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 133
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 131
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 130
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 130
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 128
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 128
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 125
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 122
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 121
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 119
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 118
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 117
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 116
DPP-4 inhibitors: Pharmacological differences and their clinical implications 116
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 116
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies. 116
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021) 114
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin. 114
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 113
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 113
Therapeutic strategies to fight COVID-19: Which is the status artis? 113
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 112
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 112
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 111
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 110
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 110
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 109
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 109
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 108
Should we abandon statins in the prevention of bone fractures? 107
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 107
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 105
Notification of undesirable effects of cosmetics and toiletries 103
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 103
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 100
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis. 98
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 90
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice 89
It is the time to change the paradigms of pregnant and breastfeeding women in clinical research! 82
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 81
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students 77
Sex and gender differences and pharmacovigilance: a knot still to be untied 69
Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines 15
Totale 11.529
Categoria #
all - tutte 37.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 0 0 3 123 10 12 9 15 16 22 109
2022/2023872 91 21 12 58 95 58 6 48 423 6 35 19
2023/2024424 26 10 30 23 122 27 12 48 21 16 29 60
2024/20251.307 10 31 28 41 180 193 194 117 195 100 114 104
2025/20266.376 254 320 311 299 510 3.368 245 495 201 160 153 60
2026/2027963 169 328 323 143 0 0 0 0 0 0 0 0
Totale 11.529